Parkinson's disease. Parkinson's disease
Conditions
Interventions
Intervention 1: Intervention group 1: Participants in this group will undergo a 12-session combined intervention program (60 minutes per session, twice weekly for 6 weeks). Each session begins with 20
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: Being at the age of 65 years or older Idiopathic Parkinson’s disease confirmed by a neurologist with a disease severity of 1–3 on the Hoehn & Yahr scale Adequate cognitive function, with a score of =24 on the Montreal Cognitive Assessment Presence of fear of falling, confirmed by a single-item question (Yes/No)
Exclusion criteria
Exclusion criteria: Comorbid neurological/orthopedic conditions affecting mobility, per physician report Substance abuse History of diabetes mellitus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Satisfaction of performance. Timepoint: Baseline, post-intervention (week 12), and follow-up (week 18). Method of measurement: The score of satisfaction with performance will be measured using the Canadian Occupational Performance Measure (COPM). This score reflects the participants' level of satisfaction with their performance in daily activities, rated on a 10-point scale, where higher scores indicate greater satisfaction.;Performance. Timepoint: Baseline, post-intervention (week 12), and follow-up (week 18). Method of measurement: The performance score will be measured using the Canadian Occupational Performance Measure (COPM). This score reflects the participants' level of performance in daily activities and is recorded on a 10-point scale, where higher scores indicate better performance. | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional mobility. Timepoint: Baseline, post-intervention (week 12), and follow-up (week 18). Method of measurement: Timed Up and Go (TUG) Test.;Self-reported confidence in maintaining balance during daily activities. Timepoint: Baseline, post-intervention (week 12), and follow-up (week 18). Method of measurement: Activities-specific Balance Confidence (ABC).;Assesses the individual's ability to maintain static and dynamic balance through 14 different tasks (e.g., standing unsupported, turning, picking up objects). Timepoint: Baseline, post-intervention (week 12), and follow-up (week 18). Method of measurement: Berg Balance Scale (BBS).;Adaptability of gait during complex walking tasks. Timepoint: Baseline, post-intervention (week 12), and follow-up (week 18). Method of measurement: Dynamic Gait Index - DGI.;Activities of Daily Living (ADL) independence. Timepoint: Baseline, post-intervention (week 12), and follow-up (week 18). Method of measurement: Barthel Index - BI.;Intrinsic motivation. Timepoint: Baseline, post-intervention (week 12), and follow-up (week 18). Method of measurement: Intrinsic Motivation Inventory - IMI.;Quality of life. Timepoint: Baseline, post-intervention (week 12), and follow-up (week 18). Method of measurement: Parkinson's Disease Questionnaire (PDQ-39).;Frequency and perceived meaningfulness of 28 daily activities. Timepoint: Baseline, post-intervention (week 12), and follow-up (week 18). Method of measurement: Meaningful Activity Participation.;Disability in daily activities specific to PD. Timepoint: Baseline, post-intervention (week 12), and follow-up (week 18). Method of measurement: UPDRS-ADL.;Concern about falling during daily activities. Timepoint: Baseline, post-intervention (week 12), and follow-up (week 18). Method of measurement: Falls Efficacy Scale-International. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGhorban Taghizadeh
Iran University of Medical Sciences
Outcome results
None listed